All In Biotech

Drug Trial Radar · NCT01372423

Evaluation of Clinical Equivalence Between Two Lubiprostone Products

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Evaluate the Clinical Equivalence of Lubiprostone 24 Mcg Capsules (Anchen Pharmaceuticals, Inc.) With AMITIZA® (Lubiprostone) 24 Mcg Capsules (Sucampo Pharmaceuticals, Inc.) in the Treatment of Chronic Idiopathic Constipation

Last checked: Nov 19, 2026Latest source record: Jul 12, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 808 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

808

Actual

Start

May 2011

Primary completion

Jun 2012

Study completion Jun 2012

Sponsor

Lead sponsor
Anchen Pharmaceuticals, IncIndustry
Sponsor type
Industry
Collaborators
Novum Pharmaceutical Research Services
First posted
Jun 14, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the clinical equivalence and safety of the Test formulation of lubiprostone 24 mcg capsules compared to the marketed formulation AMITIZA® (lubiprostone) 24 mcg capsules (Sucampo Pharmaceuticals, Inc.) in patients with confirmed chronic idiopathic constipation.

Conditions

  • Chronic Idiopathic Constipation

Interventions

  • LubiprostoneDrug

    24 mcg capsules

  • PlaceboDrug

    24 mcg capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary AnalysisTime frame: Day 8

Locations

79 sites in 1 country. Site status is shown where the registry gives one.

  • Novum Investigator Site

    Dothan, Alabama

  • Novum Investigator Site

    Huntsville, Alabama

  • Novum Investigator Site

    Mobile, Alabama

  • Novum Investigator Site

    Chandler, Arizona

  • Novum Investigator Site

    Gilbert, Arizona

  • Novum Investigator Site

    Mesa, Arizona

  • Novum Investigator Site

    Phoenix, Arizona

  • Novum Investigator Site

    Phoeniz, Arizona

  • Novum Investigator Site

    Hot Springs, Arkansas

  • Novum Investigator Site

    Little Rock, Arkansas

  • Novum Investigator Site

    Mountain Home, Arkansas

  • Novum Investigator Site

    Sherwood, Arkansas

  • Novum Investigator Site

    Buena Park, California

  • Novum Investigator Site

    Fresno, California

  • Novum Investigator Site

    Garden Grove, California

  • Novum Investigator Site

    La Palma, California

  • Novum Investigator Site

    Long Beach, California

  • Novum Investigator Site

    Sacremento, California

  • Novum Investigator Site

    San Diego, California

  • Novum Invesitgator Site

    San Ramon, California

  • Novum Investigator Site

    Santa Ana, California

  • Novum Investigator Site

    Westlake Village, California

  • Novum Investigator Site

    Denver, Colorado

  • Novum Investigator Site

    Wheat Ridge, Colorado

  • Novum Investigator Site

    Adventura, Florida

  • Novum Investigator Site

    Boyton Beach, Florida

  • Novum Investigator Site

    Bradenton, Florida

  • Novum Investigator Site

    Brookville, Florida

  • Novum Investigator Site

    Clearwater, Florida

  • Novum Investigator Site

    Deerfield Beach, Florida

  • Novum Investigator Site

    Jupiter, Florida

  • Novum Investigator Site

    Maimi, Florida

  • Novum Investigator Site

    Miami, Florida

  • Novum Investigator Site

    Niceville, Florida

  • Novum Investigator Site

    Ormond Beach, Florida

  • Novum Investigator Site

    Panama City, Florida

  • Novum Investigator Site

    Port Orange, Florida

  • Novum Investigator Site

    St. Petersburg, Florida

  • Novum Investigator Site

    Tampa, Florida

  • Novum Investigator Site

    West Palm Beach, Florida

Showing 40 of 79 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.